325 research outputs found
Collective Excitations of (154)Sm nucleus at FEL{gamma}+LHC Collider
The production of collective excitations of the (154)Sm at FEL{gamma}+LHC
collider is investigated. We show that this machine will be a powerful tool for
investigation of high energy level excitations.Comment: 6 pages, 1 figure, 4 table
ΠΠ»ΠΈΡΠ½ΠΈΠ΅ Π»Π΅ΡΠΈΡΠΈΠ½Π° ΠΈ ΠΊΠ°Π·Π΅ΠΈΠ½Π° Π½Π° ΡΠΏΠ΅ΠΊΡΡ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π±Π°ΠΊΡΠ΅ΡΠΈΠΎΡΠΈΠ½ΠΎΠ² ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΊΠΈΡΠ»ΡΡ Π±Π°ΠΊΡΠ΅ΡΠΈΠΉ, ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΈΠ· Π°Π·Π΅ΡΠ±Π°ΠΉΠ΄ΠΆΠ°Π½ΡΠΊΠΈΡ ΡΡΡΠΎΠ²
ΠΠ·ΡΡΠ΅Π½ΠΎ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π»Π΅ΡΠΈΡΠΈΠ½Π° ΠΈ ΠΊΠ°Π·Π΅ΠΈΠ½Π° Π½Π° ΡΠΏΠ΅ΠΊΡΡ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π±Π°ΠΊΡΠ΅ΡΠΈΠΎΡΠΈΠ½ΠΎΠ², Π²ΡΠ΄Π΅Π»Π΅Π½Π½ΡΡ
ΠΈΠ· ΡΡΠ°ΠΌΠΌΠΎΠ² Lactobacillus paracasei spp. paracasei BN ATS 8w, Enterococcus faecium Π5 ΠΈ Lactobacillus rhamnosus FAZ 16m. Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΏΠ°ΡΡΠΈΠ²Π½ΠΎΠΉ ΠΊΡΠ»ΡΡΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Ρ Lactobacillus bulgaricus 340, Listeria innocua Π‘IP 80.11, Escherichia coli ATCC 23355, Enterococcus faecalis ATCC 1.144. ΠΡΠΈ ΠΈΡΡΠ»Π΅Π΄ΡΠ΅ΠΌΡΡ
ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡΡ
Π»Π΅ΡΠΈΡΠΈΠ½ ΠΈ ΠΊΠ°Π·Π΅ΠΈΠ½ ΠΎΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΠΎ Π²Π»ΠΈΡΠ»ΠΈ Π½Π° Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π±Π°ΠΊΡΠ΅ΡΠΈΠΎΡΠΈΠ½ΠΎΠ². ΠΡΠΈ ΡΠ°ΠΊΡΠΎΡΡ Π²Ρ
ΠΎΠ΄ΡΡ Π² ΡΠΎΡΡΠ°Π² Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π° ΡΠ΅ΡΠΌΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ²
The Effect of the Pairing Interaction on the Energies of Isobar Analog Resonances in Sb and Isospin Admixture in Sn Isotopes
In the present study, the effect of the pairing interaction and the isovector
correlation between nucleons on the properties of the isobar analog resonances
(IAR) in Sb isotopes and the isospin admixture in Sn
isotopes is investigated within the framework of the quasiparticle random phase
approximation (QRPA). The form of the interaction strength parameter is related
to the shell model potential by restoring the isotopic invariance of the
nuclear part of the total Hamiltonian. In this respect, the isospin admixtures
in the Sn isotopes are calculated, and the dependence of the
differential cross section and the volume integral for the
Sn(He,t)Sb reactions at E(He) MeV occurring by the excitation
of IAR on mass number A is examined. Our results show that the calculated value
for the isospin mixing in the Sn isotope is in good agreement with Colo
et al.'s estimates , and the obtained values for the volume integral
change within the error range of the value reported by Fujiwara et al.
(535 MeV fm). Moreover, it is concluded that although the
differential cross section of the isobar analog resonance for the (He,t)
reactions is not sensitive to pairing correlations between nucleons, a
considerable effect on the isospin admixtures in isotopes can be
seen with the presence of these correlations.Comment: 16 pages, 5 EPS figures and 2 tables, Late
Errors in chromosome segregation during oogenesis and early embryogenesis
Errors in chromosome segregation occurring during human oogenesis and early embryogenesis are very common. Meiotic chromosome development during oogenesis is subdivided into three distinct phases. The crucial events, including meiotic chromosome pairing and recombination, take place from around 11 weeks until birth. Oogenesis is then arrested until ovulation, when the first meiotic division takes place, with the second meiotic division not completed until after fertilization. It is generally accepted that most aneuploid fetal conditions, such as trisomy 21 Down syndrome, are due to maternal chromosome segregation errors. The underlying reasons are not yet fully understood. It is also clear that superimposed on the maternal meiotic chromosome segregation errors, there are a large number of mitotic errors taking place post-zygotically during the first few cell divisions in the embryo. In this chapter, we summarise current knowledge of errors in chromosome segregation during oogenesis and early embryogenesis, with special reference to the clinical implications for successful assisted reproduction
A pilot study of application of the Stroke Riskometer mobile app for assessment of the course and clinical outcomes of COVID-19 among hospitalised patients
Early determination of COVID-19 severity and health outcomes could facilitate better treatment of patients. Different methods and tools have been developed for predicting outcomes of COVID-19, but they are difficult to use in routine clinical practice. Methods: We conducted a prospective cohort study of inpatients aged 20-92 years, diagnosed with COVID-19 to determine whether their individual 5-year absolute risk of stroke at the time of hospital admission predicts the course of COVID-19 severity and mortality. The risk of stroke was determined by the Stroke Riskometer mobile application. Results: We examined 385 patients hospitalised with COVID-19 (median age 61 years). The participants were categorised based on COVID-19 severity: 271 (70.4%) to the βNot severeβ and 114 (29.6%) to the βSevereβ groups. The median risk of stroke the next day after hospitalisation was significantly higher among patients in the Severe group (2.83 [95% CI 2.35-4.68]) vs the Not severe group (1.11 [95% CI 1.00β1.29]). The median risk of stroke and median systolic blood pressure (SBP) were significantly higher among non-survivors (12.04 [95% CI 2.73-21.19]) and (150 [95% CI 140-170]) vs survivors (1.31 [95% CI 1.14-1.52]), 134 [95% CI 130-135]), respectively. Those who spent more than 2.5 hours a week on physical activity were 3.1 times more likely to survive from COVID-19. Those who consumed more than one standard alcohol drink a day, or suffered with atrial fibrillation, or had poor memory were 2.5, 2.3, and 2.6 times more likely not to survive from COVID-19, respectively. Conclusions: High risk of stroke, physical inactivity, alcohol intake, high SBP, and atrial fibrillation are associated with severity and mortality of COVID-19. Our findings suggest that the Stroke Riskometer app could be used as a simple predictive tool of COVID-19 severity and mortality
ΠΠΈΠΎΡ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠ½ΠΎΠ²Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΏΡΠΈ ΠΏΠΎΠ·ΠΈΡΡΠΎΠ½Π½ΠΎΠΉ ΡΠΌΠΈΡΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ Π² ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ. Π§Π°ΡΡΡ 2
This article provides an overview of the main literature data of biochemical basics and the clinical applicationΒ of positron emission tomography, one of the promising technologies of radiation imaging in oncology.In the current part we discuss in detail the biokinetics of radiopharmaceuticals used to visualize various groupsΒ of tumor cells receptors. These include angiogenesis markers - RGD peptides, ligands for somatostatin receptors, agents for sex hormone imaging, ligands for prostate-specific membrane antigen and to activating EGFR mutantΒ kinase. It contains results of studies that were dedicated to search for optimal modifications of these radiopharmaceuticals to increase diagnostic efficiency, their comparative analysis is carried out, the results of their use in cancer research and development prospects in this industry are highlighted.ΠΠ°ΡΡΠΎΡΡΠ°Ρ ΡΡΠ°ΡΡΡ ΡΠΎΠ΄Π΅ΡΠΆΠΈΡ ΠΎΠ±Π·ΠΎΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΡ
Π΄Π°Π½Π½ΡΡ
, ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π½ΡΡ
Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΎΡΠ½ΠΎΠ²Π°ΠΌ ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΠΎΠ·ΠΈΡΡΠΎΠ½Π½ΠΎΠΉ ΡΠΌΠΈΡΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΠΈ β ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ Π»ΡΡΠ΅Π²ΠΎΠΉ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ Π² ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ.Π Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°ΡΡΠΈ ΠΏΠΎΠ΄ΡΠΎΠ±Π½ΠΎ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π±ΠΈΠΎΠΊΠΈΠ½Π΅ΡΠΈΠΊΠΈ ΡΠ°Π΄ΠΈΠΎΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ²,Β ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΠΌΡΡ
Π΄Π»Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π³ΡΡΠΏΠΏ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠΎΠ², ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π½ΡΡ
Π² ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΠΊΠ»Π΅ΡΠΊΠ°Ρ
. Π Π½ΠΈΠΌΒ ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΌΠ°ΡΠΊΠ΅ΡΡ Π°Π½Π³ΠΈΠΎΠ³Π΅Π½Π΅Π·Π° β RGD-ΠΏΠ΅ΠΏΡΠΈΠ΄Ρ, Π»ΠΈΠ³Π°Π½Π΄Ρ ΠΊ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ°ΠΌ ΡΠΎΠΌΠ°ΡΠΎΡΡΠ°ΡΠΈΠ½Π°, Π°Π³Π΅Π½ΡΡ Π΄Π»Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠΎΠ² ΠΊ ΠΏΠΎΠ»ΠΎΠ²ΡΠΌ Π³ΠΎΡΠΌΠΎΠ½Π°ΠΌ, Π»ΠΈΠ³Π°Π½Π΄Ρ ΠΊ ΠΏΡΠΎΡΡΠ°ΡΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΌΡ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΎΠΌΡ Π°Π½ΡΠΈΠ³Π΅Π½ΡΒ ΠΈ ΠΊΠΈΠ½Π°Π·Π΅, Π°ΠΊΡΠΈΠ²ΠΈΡΡΠ΅ΠΌΠΎΠΉ ΠΌΡΡΠ°ΡΠΈΠ΅ΠΉ EGFR. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎ ΠΏΠΎΠΈΡΠΊΡ ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½ΡΡ
Β ΠΌΠΎΠ΄ΠΈΡΠΈΠΊΠ°ΡΠΈΠΉ ΡΡΠΈΡ
ΡΠ°Π΄ΠΈΠΎΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π΄Π»Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ,Β ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΈΡ
ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·, ΠΎΡΠ²Π΅ΡΠ΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡ
ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎΒ ΠΏΡΠΎΡΠΈΠ»Ρ ΠΈ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π² Π΄Π°Π½Π½ΠΎΠΉ ΠΎΡΡΠ°ΡΠ»ΠΈ
- β¦